![MedinCell: Phase 3 Data of mdc-IRM, First Product Based on MedinCell's Technology, Shows Significant Improvements in Patients With Schizophrenia MedinCell: Phase 3 Data of mdc-IRM, First Product Based on MedinCell's Technology, Shows Significant Improvements in Patients With Schizophrenia](https://www.finanznachrichten.de/chart-medincell-sa-aktie-intraday-frankfurt.png)
MedinCell: Phase 3 Data of mdc-IRM, First Product Based on MedinCell's Technology, Shows Significant Improvements in Patients With Schizophrenia
![Teva's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile Teva's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/logo/teva_owler_20161021_123931_original.png)
Teva's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
![Teva Says Clinical Programs Reinforce The Potential AJOVY Can Have For Patients Living With Migraine Teva Says Clinical Programs Reinforce The Potential AJOVY Can Have For Patients Living With Migraine](https://www.finanznachrichten.de/chart-teva-pharmaceutical-industries-ltd-aktie-intraklein-tg.png)
Teva Says Clinical Programs Reinforce The Potential AJOVY Can Have For Patients Living With Migraine
![Teva Pharmaceutical Industries Ltd.: Teva receives EU Marketing Authorisation for Seffalair Spiromax and BroPair Spiromax (salmeterol xinafoate / fluticasone propionate) Teva Pharmaceutical Industries Ltd.: Teva receives EU Marketing Authorisation for Seffalair Spiromax and BroPair Spiromax (salmeterol xinafoate / fluticasone propionate)](https://www.finanznachrichten.de/chart-teva-pharmaceutical-industries-ltd-aktie-intraday-tg.png)
Teva Pharmaceutical Industries Ltd.: Teva receives EU Marketing Authorisation for Seffalair Spiromax and BroPair Spiromax (salmeterol xinafoate / fluticasone propionate)
![Teva Pharmaceutical Industries Ltd.: Teva receives EU Marketing Authorisation for Seffalair Spiromax and BroPair Spiromax (salmeterol xinafoate / fluticasone propionate) Teva Pharmaceutical Industries Ltd.: Teva receives EU Marketing Authorisation for Seffalair Spiromax and BroPair Spiromax (salmeterol xinafoate / fluticasone propionate)](https://www.finanznachrichten.de/chart-teva-pharmaceutical-industries-ltd-aktie-1jahrklein-tg.png)